Vanguard reports 6.38M PRVA shares (5.16%)
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vanguard Portfolio Management filed a Schedule 13G reporting beneficial ownership of 6,382,685 shares of Privia Health Group Inc. The filing shows this position represents 5.16% of the class and reports 101,143 shares of sole voting power and 6,382,685 shares of sole dispositive power as of 03/31/2026.
The disclosure includes Vanguard's customary explanatory statement: the holdings reflect securities over which Vanguard Portfolio Management LLC and certain affiliates exercise dispositive power, including shares held by Vanguard funds and managed accounts.
Insights
Vanguard reports a passive >5% stake in PRVA, typical for index/managed-fund ownership.
The Schedule 13G lists 6,382,685 shares representing 5.16% of the class as of 03/31/2026, with sole dispositive power noted. This aligns with common institutional disclosure practice for fund-managed positions.
Cash-flow treatment and trading intentions are not specified; subsequent filings or amendments could update percentage or voting details.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
sole dispositive power financial
sole voting power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake did Vanguard report in PRVA on the Schedule 13G?
What date anchors the ownership figures in Vanguard's filing for PRVA?
AI-generated analysis. How Rhea-AI works. Not financial advice.